← Back to screener

Biohaven Ltd. BHVN

Rank #2238 · NYSE · $2.3B market cap
⚠ Going-concern flag — the auditor (Ernst & Young LLP) raised substantial doubt about this company's ability to continue operating in the latest filing. Read the actual filing before drawing conclusions.
Score
27.9
P/E
-5.7
P/B
4.31
ROE
-75.8%
Op. Margin
–%
Debt Ratio
36%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆
Weak

P/E -5.7x, P/B 4.31x. Ranks in the top 75% of the universe.

Profitability ★☆☆☆☆
Poor

ROE -75.8%. Ranks in the top 92% of the universe.

Safety ★★★★☆
Excellent

Debt ratio 36%. Ranks in the top 19% of the universe. Under 100% is generally considered a safe level.

Growth –
No data

Not enough historical filings to compute year-over-year growth yet.

Safety is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2022–$-0.1B$-0.1B$0.0B–328
2023–$-0.2B$-0.2B$0.0B–733
2024–$-0.6B$-0.6B$0.0B–246
2025–$-0.4B$-0.4B$0.5B–36

← See the full screener